Company: ARVN
Filing Date: 2025-06-06
Form Type: 8-K
Source: 0001655759-25-000100
Chunk: 0

Company: ARVINAS, INC.
Filing Date: 2025-06-06
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 4, 2025, Ian Taylor, Ph. D., President of Research and Development of Arvinas, Inc. (the “ Company”), notified the Company of his decision to resign his employment with the Company and retire, effective June 6, 2025 (the “ Resignation Date”). On the Resignation Date, in connection with his resignation, Dr. Taylor and the Company entered into a Consulting Agreement, pursuant to which Dr. Taylor has agreed to provide consulting and advisory services to the Company for one year from the Resignation Date (the “ Consulting Period”), unless earlier terminated by the Company or Dr. Taylor with at least 10 business days' prior written notice. Dr. Taylor plans to remain as chair of the Company’s Scientific Advisory Board. Pursuant to the Consulting Agreement, Dr. Taylor will be paid an hourly rate for his services during the Consulting Period.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                          ARVINAS, INC.                               
  Date: June 6, 2025      By:                /s/ Andrew Saik          
                                             Andrew Saik